Skip to content

Clinical trials

Phase 1/2 Urinary Bladder Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urinary Bladder Neoplasms Phase: Phase 1/2 Country / region: China Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20201
20214
20222
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Not yet recruiting3
Unknown status3
Active, not recruiting2
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University2
AstraZeneca1
Essen Biotech1
Fudan University1
LintonPharm Co.,Ltd.1
Pfizer1
RenJi Hospital1
Shanghai Escugen Biotechnology Co., Ltd1
Shenzhen Geno-Immune Medical Institute1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urinary Bladder Neoplasms16
Breast Neoplasms4
Colorectal Neoplasms4
Stomach Neoplasms4
Ovarian Neoplasms3
Prostatic Neoplasms3
Biliary Tract Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Lung Neoplasms2
Pancreatic Neoplasms2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.